2024-05-09 16:28:52 ET
More on Zomedica
- Zomedica Corp. (ZOM) Q4 2023 Earnings Call Transcript
- Financial information for Zomedica
Read the full article on Seeking Alpha
For further details see:
Zomedica GAAP EPS of $0.01, revenue of $6.3M2024-05-09 16:28:52 ET
Read the full article on Seeking Alpha
For further details see:
Zomedica GAAP EPS of $0.01, revenue of $6.3MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Zomedica Pharmaceuticals Corp. Company Name:
ZOM Stock Symbol:
Market:
Zomedica Pharmaceuticals Corp. Website:
PulseVet ® Shock Wave Device Supports Equine Athletes Ahead of Major International Team Events ANN ARBOR, MI / ACCESSWIRE / July 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therape...
First-of-its-kind stall-side testing to enable rapid, life-saving decisions for equine veterinarians ANN ARBOR, MI / ACCESSWIRE / June 27, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for ...
CE mark enables launch of the TRUFORMA ® Diagnostic Platform into the European Union ANN ARBOR, MI / ACCESSWIRE / June 25, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products fo...